AB-836, identified by its CAS number 2445597-31-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like AB-836 are typically evaluated for their pharmacological properties, including efficacy, safety, and mechanism of action. It is often studied in the context of neurological disorders or other medical conditions, reflecting its relevance in drug development. The compound's stability, reactivity, and interaction with biological systems are also critical factors that researchers consider. Additionally, the synthesis and purification methods employed can influence the compound's characteristics and overall performance in biological assays. As research progresses, more detailed information regarding its specific properties and applications may become available, contributing to a better understanding of its role in therapeutic contexts.

AB-836

2445597-31-7: AB-836, identified by its CAS number 2445597-31-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like AB-836 are typically evaluated for their pharmacological properties, including efficacy, safety, and mechanism of action. It is often studied in the context of neurological disorders or other medical conditions, reflecting its relevance in drug development. The compound's stability, reactivity, and interaction with biological systems are also critical factors that researchers consider. Additionally, the synthesis and purification methods employed can influence the compound's characteristics and overall performance in biological assays. As research progresses, more detailed information regarding its specific properties and applications may become available, contributing to a better understanding of its role in therapeutic contexts.

(R)-3-(3-Cyano-4-fluorophenyl)-1-(1-(6,7-difluoro-1-oxo-1,2-dihydroisoquinolin-4-yl)ethyl)-1-methylurea

AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.

CAS 2445597-31-7

AB-836

(R)-3-(3-Cyano-4-fluorophenyl)-1-(1-(6,7-difluoro-1-oxo-1,2-dihydroisoquinolin-4-yl)ethyl)-1-methylurea

Ref: 54-PC1007705

AB-836

Ref: TM-T73492